Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Apple Inc AAPL

Alternate Symbol(s):  N.AAPL

Apple Inc. designs, manufactures and markets smartphones, personal computers, tablets, wearables and accessories, and sells a variety of related services. Its product categories include iPhone, Mac, iPad, and Wearables, Home and Accessories. Its software platforms include iOS, iPadOS, macOS, watchOS, and tvOS. Its services include advertising, AppleCare, cloud services, digital content and payment services. It operates various platforms, including the App Store, that allow customers to discover and download applications and digital content, such as books, music, video, games and podcasts. It also offers digital content through subscription-based services, including Apple Arcade, Apple Fitness+, Apple Music, Apple News+ and Apple TV+. Its products include iPhone 15 Pro, iPhone 15, iPhone 14, iPhone 13, MacBook Air, MacBook Pro, iMac, Mac mini, Mac Studio, Mac Pro, and others. It also provides DarwinAI, which specializes in visual quality inspection using its Explainable AI platform.


NDAQ:AAPL - Post by User

<< Previous
Bullboard Posts
Next >>
Post by zayaroy18on May 05, 2022 5:41am
191 Views
Post# 34657644

Wearable Medical Device Market Size Report, 2022-2027

Wearable Medical Device Market Size Report, 2022-2027

 The global wearable medical devices market size reached a US$ 18.96 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 60.55 Billion by 2027, exhibiting at a CAGR of 22.2% during 2022-2027. 

Report Metric

Historical: 2016-2021

Base Year: 2021

Forecast Year: 2022-2027

Wearable medical devices represent autonomous instruments that are non-invasively attached to the body to provide medical monitoring or support. They include various diagnostic devices, such as those that monitor glucose levels, vital signs, sleep, fetal well-being, the nervous system, etc., and numerous therapeutic devices for rehabilitation pain management and respiratory therapy. Wearable medical devices consist of biosensors, controllers, and software systems for data acquisition, interpretation, transfer, and storage. They incorporate noninvasive physiological sensors, wireless data transmission capabilities, medical feedback, data processing modules, etc. Wearable medical devices also provide supporting hardware to cater to point-of-care treatments. They are extensively utilized by consumers across the globe.

Global Wearable Medical Devices Market Trends:

The expanding geriatric population, who are more susceptible to chronic diseases, is among the primary factors driving the wearable medical devices market. Apart from this, the escalating product demand across healthcare centers, on account of the sudden outbreak of the COVID-19 pandemic, is further catalyzing the market growth. Additionally, the increasing adoption of these devices for monitoring, providing feedback, rehabilitation, disease management, suggesting adequate treatments, etc., is acting as another significant growth-inducing factor. Besides this, the inflating product utilization in monitoring physiological information, such as photoplethysmography (PPG), biopotential, blood pressure (BP), etc., is also augmenting the global market. Furthermore, the development of patches, smartwatches, and smart clothing that are integrated with the Internet of Things (IoT) to assist in monitoring various fitness parameters, including footstep count, calories burned, distance walked, etc., is anticipated to fuel the wearable medical devices market over the forecasted period.

Request Free Sample Report: https://www.imarcgroup.com/wearable-medical-devices-market/requestsample

Global Wearable Medical Devices Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Abbott Laboratories, Apple Inc., Dexcom Inc., Fitbit Inc. (Google LLC), Garmin Ltd., Honeywell International Inc., Koninklijke Philips N.V., Medtronic Plc, Omron Corporation and Vital Connect Inc.

The report has segmented the market on the basis on region, device type, product, application and distribution channel.

Breakup by Device Type:

  • Diagnostic Devices
    • Vital Sign Monitoring
    • Sleep Monitoring
    • Electrocardiographs and Obstetric Devices
    • Neuromonitoring Devices
  • Therapeutic Devices
    • Pain Management Devices
    • Insulin Delivery Devices
    • Rehabilitation Devices
    • Respiratory Therapy Devices

Breakup by Product:

  • Activity Monitors
  • Smartwatches
  • Patches
  • Smart Clothing
  • Hearing Aids
  • Others

Breakup by Application:

  • Sports and Fitness
  • Remote Patient Monitoring
  • Home Healthcare

Breakup by Distribution Channel:

  • Offline
  • Online

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/wearable-medical-devices-market

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

Company Name: IMARC Group
Email: sales@imarcgroup.com
Toll Free Number: USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

 

<< Previous
Bullboard Posts
Next >>